Articles with "post dose" as a keyword



Photo from wikipedia

Deterioration of Nighttime Respiratory Mechanics in Chronic Obstructive Pulmonary Disease: Impact of Bronchodilator Therapy.

Sign Up to like & get
recommendations!
Published in 2020 at "Chest"

DOI: 10.1016/j.chest.2020.06.033

Abstract: BACKGROUND Chronic Obstructive Pulmonary Disease (COPD) is associated with nighttime respiratory symptoms, poor sleep quality, and increased risk of nocturnal mortality. Overnight deterioration of inspiratory capacity (IC) and forced expiratory volume in 1 second (FEV1)… read more here.

Keywords: chronic obstructive; deterioration; hours post; respiratory mechanics ... See more keywords
Photo by freestocks from unsplash

341 Acute effects of seltorexant, a selective orexin-2 antagonist (JNJ- 42847922), on driving after bedtime administration

Sign Up to like & get
recommendations!
Published in 2021 at "Sleep"

DOI: 10.1093/sleep/zsab072.340

Abstract: Seltorexant (JNJ-42847922), a potent and selective antagonist of the human orexin-2 receptor, is being developed for the treatment of major depressive disorder. Seltorexant also has sleep-promoting properties. Investigating the effects of sleep-promoting medications on driving… read more here.

Keywords: administration; placebo; jnj 42847922; driving ... See more keywords
Photo by cdc from unsplash

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo

Sign Up to like & get
recommendations!
Published in 2022 at "BMJ Open"

DOI: 10.1136/bmjopen-2021-055596

Abstract: Introduction Ebola virus disease (EVD) continues to be a significant public health problem in sub-Saharan Africa, especially in the Democratic Republic of the Congo (DRC). Large-scale vaccination during outbreaks may reduce virus transmission. We established… read more here.

Keywords: virus disease; trial; two dose; ebola virus ... See more keywords
Photo from wikipedia

Abstract 4326: Predictive value of CXCL10 for the occurrence of immune related adverse events in patient with renal cell carcinoma

Sign Up to like & get
recommendations!
Published in 2023 at "Cancer Research"

DOI: 10.1158/1538-7445.am2023-4326

Abstract: Background: Immune checkpoint inhibitors (ICIs) have recently improved the prognosis of various cancers. In contrast, some immune-related adverse events (irAEs) caused by ICIs are fatal and have become problematic. The pathogenesis of irAEs remains unknown… read more here.

Keywords: immune related; plasma; occurrence; cxcl10 ... See more keywords
Photo by son_of_media from unsplash

Improvements in throat function and qualities of sore throat from locally applied flurbiprofen 8.75 mg in spray or lozenge format: findings from a randomized trial of patients with upper respiratory tract infection in the Russian Federation

Sign Up to like & get
recommendations!
Published in 2018 at "Journal of Pain Research"

DOI: 10.2147/jpr.s149331

Abstract: Objective To assess the speed of relief provided by flurbiprofen 8.75 mg spray and lozenge and their effect on many of the different qualities and characteristics of throat pain and discomfort, and the many articulations… read more here.

Keywords: hours post; throat; spray lozenge; flurbiprofen spray ... See more keywords